New Zealand
· Delayed Price · Currency is NZD Rua Bioscience Statistics
Total Valuation
Rua Bioscience has a market cap or net worth of NZD 5.91 million. The enterprise value is 5.88 million.
| Market Cap | 5.91M |
| Enterprise Value | 5.88M |
Important Dates
The last earnings date was Monday, February 24, 2025.
| Earnings Date | Feb 24, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Rua Bioscience has 218.85 million shares outstanding. The number of shares has increased by 0.66% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 218.85M |
| Shares Change (YoY) | +0.66% |
| Shares Change (QoQ) | +1.26% |
| Owned by Insiders (%) | 24.61% |
| Owned by Institutions (%) | n/a |
| Float | 144.27M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 4.10 |
| PB Ratio | 0.71 |
| P/TBV Ratio | 1.45 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -1.26 |
| EV / Sales | 5.53 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.08, with a Debt / Equity ratio of 0.08.
| Current Ratio | 2.08 |
| Quick Ratio | 0.83 |
| Debt / Equity | 0.08 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -78.92 |
Financial Efficiency
Return on equity (ROE) is -59.31% and return on invested capital (ROIC) is -30.71%.
| Return on Equity (ROE) | -59.31% |
| Return on Assets (ROA) | -28.41% |
| Return on Invested Capital (ROIC) | -30.71% |
| Return on Capital Employed (ROCE) | -63.63% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.12 |
| Inventory Turnover | 2.35 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -61.94% in the last 52 weeks. The beta is 0.28, so Rua Bioscience's price volatility has been lower than the market average.
| Beta (5Y) | 0.28 |
| 52-Week Price Change | -61.94% |
| 50-Day Moving Average | 0.03 |
| 200-Day Moving Average | 0.04 |
| Relative Strength Index (RSI) | 50.05 |
| Average Volume (20 Days) | 152,992 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Rua Bioscience had revenue of NZD 1.06 million and -4.67 million in losses. Loss per share was -0.03.
| Revenue | 1.06M |
| Gross Profit | 393,612 |
| Operating Income | -4.03M |
| Pretax Income | -4.67M |
| Net Income | -4.67M |
| EBITDA | -3.82M |
| EBIT | -4.03M |
| Loss Per Share | -0.03 |
Balance Sheet
The company has 538,646 in cash and 512,731 in debt, giving a net cash position of 25,915 or 0.00 per share.
| Cash & Cash Equivalents | 538,646 |
| Total Debt | 512,731 |
| Net Cash | 25,915 |
| Net Cash Per Share | 0.00 |
| Equity (Book Value) | 6.27M |
| Book Value Per Share | 0.04 |
| Working Capital | 1.49M |
Cash Flow
| Operating Cash Flow | -3.55M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | 36.99% |
| Operating Margin | -379.13% |
| Pretax Margin | -438.77% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Rua Bioscience does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.66% |
| Shareholder Yield | -0.66% |
| Earnings Yield | -79.02% |
| FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |